Physician and Patient Barriers to Breast Cancer Preventive Therapy
The uptake of selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) for the primary prevention of breast cancer is low, despite their proven efficacy in several randomized clinical trials. This review summarizes the latest data on physicians’ and women’s barriers to breast ca...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer US
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995234/ |